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Abstract Objective To compare different treatment protocols for sudden deafness（SD）, for the purpose of identify⁃
ing an appropriate approach to SD. Methods A total of 104 patients with diagnosis of sudden hearing loss treated
from Jan 2006 to December 2008 were included in this study, of which 31 received the typical pharmaceutical treat⁃
ment（groupⅠ）, 40 received the typical pharmaceutical treatment plus polarized liquid（GroupⅡ）and 33 received
the hyperbaric oxygen in addition to the treatment included in Group Ⅱ（Group Ⅲ）． Results The total improve⁃
ment rate（67.74%, 62.50% and 75.76% for Groups Ⅰ, Ⅱ and Ⅲ respectively）was not statistically different be⁃
tween the three groups（P>0.05）. Conclusion The three treatment protocols are similar when judged by the treat⁃
ment outcomes in SD, neither being superior to the others. The two important factors that appear to influence treat⁃
ment outcomes are the audiogram pattern and duration of hearing loss before seeking treatment. Patients with upslop⁃
ing or peak-type audiograms and treated within 7 days from the onset have better prognosis than others.
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Intrduction
Sudden deafness is a syndrome covering several heter⁃
ogenous entities resulting from different pathogenetic
mechanisms, which is believed to affect 1:5 000 people
yearly. The various therapeutic strategies currently rec⁃
ommended are highly empirical and should be ques⁃
tioned in terms of cost-effectiveness. The authors con⁃
ducted a retrospective case review study to determine
therapeutic effects of different treatment protocols on
sudden hearing loss, in an attempt to identify an appro⁃
priate protocol to improve our approach to SD.
Subjects and methods
The diagnostic criteria for sudden hearing loss in this
study was an acute onset of hearing loss of 30 dB at 3
contiguous frequencies that occurred either instanta⁃
neously or progressively over several days［1］.
Subjects were patients presenting with sudden hear⁃
ing loss who satisfied the following conditions:(1) idio⁃
pathetic unilateral sensorineural hearing loss, (2) no pos⁃
itive central nervous system findings, (3) diagnosed with⁃
in 60 days after the onset of hearing loss, (4) previously
untreated, and (5) normal hearing in the opposite ear for
age.
A total of 104 patients（53 males and 51 females，av⁃
erage age=44.9 years, ranging from 25 to 60 years）treat⁃
ed between Jan 2006 and December 2008 were includ⁃
ed in this study. Thirty one cases（GroupⅠ）received
the typical treatment including intravenous steroids，va⁃
sodilator, low-molecular-weight dextran and orally Ca2 +
channel blocker. Polarized liquid was used in 40 cases
in addition to the Group Ⅰprotocol（Group Ⅱ）. The re⁃
maining 33 cases（Group Ⅲ）received hyperbaric oxy⁃
gen as well as the treatments employed in GroupsⅠand
Ⅱ．
Evaluation of hearing recovery followed the criteria
by Goodman, i.e., complete recovery: average threshold
across 250, 500, 1 000, 2 000, and 4 000 Hz within 20
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dB HL or equal to that of the opposite ear; marked recov⁃
ery: hearing gain of more than 30 dB in average thresh⁃
old; partial recovery: hearing gain between 10 dB and
30 dB in average threshold; and unchanged: an average
hearing gain within 10 dB.
Statistical analysis：The effect of treatment was ana⁃
lyzed using χ2 test, with P < 0.05 being considered sig⁃
nificant.
Results
The total effective rate in each group was 67.74% ,
62.50% and 75.76% respectively and not statistically
different between the three groups（P> 0.05)（table 1）.
Relationship between audiogram patterns and treat⁃
ment outcomes:
Initial audiograms were divided into seven types in or⁃
der to compare the relationship between therapeutic re⁃
sults and audiogram contours, including peak-type
（4.4%）, flat（24.3%）, down-sloping（21.3%）, and up⁃
ward-sloping（17%）contours. All cases with peak-type
audiograms and 84.6% of cases with upward-sloping
（low-frequency loss）audiograms showed complete re⁃
covery. However, the extremely low number of patients
with peak-type audiograms made statistical analysis dif⁃
ficult. Complete recovery was achieved in 78.3% of cas⁃
es with flat-type audiograms and mild and moderate-se⁃
vere deafness, and 61.0% if the deafness was extremely
severe. For these cases, most threshold improvement
took place at low to intermediate frequencies. Only
44.4% of patients with downward-sloping audiograms
（high-frequency loss）showed complete recovery, sig⁃
nificantly poorer than others audiogram patterns（χ2 =
9.58, P< 0.05）.
Effects of interval between onset and treatment on
treatment outcomes:
The time from the onset to the initial visit was divided
into 5 parts for comparison purposes, including 1-7
days, 8-15 days, 16-30 days and more than 60 days.
Treatment outcomes were excellent when the patient
sought treatment within 7 days from the onset of hearing
loss, with 77.8% achieving complete recovery and
94.7% obtaining at least partial recovery. When com⁃
bined with those treated within 15 days, the rates were
83.4% and 100% respectively. Whereas, after 31- 60
days, patients were less likely to benefit from therapy, al⁃
though there were 3 cases showing complete recovery
and 2 cases showing marked recovery. In those who re⁃
ceived treatment after 60 days from onset of hearing
loss, only 1 case responded to treatment.
Discussion
Evaluation of treatment effects by the therapeutic proto⁃
cols:
The total effective rate is not statistically different
when the three treatment protocols are compared. The
result show that different combination of medicine and
therapeutic methods do not influence treatment out⁃
comes in SD. No particular treatment protocol appears
superior to others.
Numerous causes have been speculated for sudden
deafness, although rarely a specific underlying cause is
reliably identified for any case. A cause can be deter⁃
mined in only 10 to 15% of patients with SD. A diagno⁃
sis of SD is generally based on the patient's medical his⁃
tory. Possible causes include infection, trauma（such as
a head injury）, abnormal tissue growth, immunologic
diseases（such as Cogan's syndrome［2］）, toxicity（such as
snake bites）, toxic drugs（ototoxic drugs）; circulatory
disorders［3，4］, neurologic conditions（such as multiple
sclerosis）, and otologic conditions such as Ménière's
disease. Immunologic disorders and microvascular
events have been suggested to play an important role in
SD. Therefore, before definite pathogenesis can be deter⁃
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microcirculation and protecting neural function［5］.
Hyperbaric oxygen（HBO） therapy has previously
been suggested as an adjunctive treatment. In our study,
however, HBO and polarized liquid failed to show any
additional advantages, similar to some existing reports
［6］. HBO therefore should only be considered for SD
when there are contraindications to standard medical
treatment. This opinion has been disputed in the litera⁃
ture［7］, as treatment with HBO and anti-oxygen-derived
free radicals can improve oxygen supply to the cerebral
tissue, which is beneficial to senile SD patients.
The course of treatment:
In the first 30 treatment days, improvement appears
to increase along with treatment time, from 50.8% to
84.7% , although for most patients, auditory threshold
improvement show little change beyond 15 days of treat⁃
ment. Few cases continue to show recovery after 1
month. Treatment can continue for 1-2 months if there
are no contraindications.
Prognosis can be predicted at approximately 2 weeks
after start of treatment, as recovery appears to plateau af⁃
ter 2 weeks of treatment ［8］. Hearing should be fol⁃
lowed-up for 2-6 months after treatment in patients
who show incomplete or delayed hearing improvement.
Factors influencing the therapeutic outcomes:
In our study, the two important factors that influenced
hearing recovery were the pattern of audiogram and du⁃
ration of hearing loss before seeking treat－ ment［9］.
Patients with low-frenquency or peak-type audiograms,
treated within 7 days from the onset showed better prog⁃
nosis than others.
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